202 related articles for article (PubMed ID: 21909097)
21. Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication.
Kuss-Duerkop SK; Wang J; Mena I; White K; Metreveli G; Sakthivel R; Mata MA; Muñoz-Moreno R; Chen X; Krammer F; Diamond MS; Chen ZJ; García-Sastre A; Fontoura BMA
PLoS Pathog; 2017 Sep; 13(9):e1006635. PubMed ID: 28953980
[TBL] [Abstract][Full Text] [Related]
22. Influenza virus non-structural protein NS1: interferon antagonism and beyond.
Marc D
J Gen Virol; 2014 Dec; 95(Pt 12):2594-2611. PubMed ID: 25182164
[TBL] [Abstract][Full Text] [Related]
23. Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.
Shih SR; Chu TY; Reddy GR; Tseng SN; Chen HL; Tang WF; Wu MS; Yeh JY; Chao YS; Hsu JT; Hsieh HP; Horng JT
J Biomed Sci; 2010 Feb; 17(1):13. PubMed ID: 20178582
[TBL] [Abstract][Full Text] [Related]
24. Identification, design and synthesis of novel pyrazolopyridine influenza virus nonstructural protein 1 antagonists.
Patnaik S; Basu D; Southall N; Dehdashti S; Wan KK; Zheng W; Ferrer M; Taylor M; Engel DA; Marugan JJ
Bioorg Med Chem Lett; 2019 May; 29(9):1113-1119. PubMed ID: 30852083
[TBL] [Abstract][Full Text] [Related]
25. Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice.
Rajput R; Khanna M; Kumar P; Kumar B; Sharma S; Gupta N; Saxena L
Nucleic Acid Ther; 2012 Dec; 22(6):414-22. PubMed ID: 23062009
[TBL] [Abstract][Full Text] [Related]
26. Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR.
Schierhorn KL; Jolmes F; Bespalowa J; Saenger S; Peteranderl C; Dzieciolowski J; Mielke M; Budt M; Pleschka S; Herrmann A; Herold S; Wolff T
J Virol; 2017 May; 91(10):. PubMed ID: 28250123
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin.
Jang SK; Hong SE; Lee DH; Kim JY; Kim JY; Ye SK; Hong J; Park IC; Jin HO
BMC Cancer; 2021 Jul; 21(1):803. PubMed ID: 34253170
[TBL] [Abstract][Full Text] [Related]
28. Nuclear factor of activated T-cell c3 inhibition of mammalian target of rapamycin signaling through induction of regulated in development and DNA damage response 1 in human intestinal cells.
Zhou Y; Wang Q; Guo Z; Weiss HL; Evers BM
Mol Biol Cell; 2012 Aug; 23(15):2963-72. PubMed ID: 22696685
[TBL] [Abstract][Full Text] [Related]
29. Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.
Nogales A; Martinez-Sobrido L; Chiem K; Topham DJ; DeDiego ML
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021892
[TBL] [Abstract][Full Text] [Related]
30. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
Nacken W; Ehrhardt C; Ludwig S
Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
[TBL] [Abstract][Full Text] [Related]
31. Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases.
Krumm SA; Ndungu JM; Yoon JJ; Dochow M; Sun A; Natchus M; Snyder JP; Plemper RK
PLoS One; 2011; 6(5):e20069. PubMed ID: 21603574
[TBL] [Abstract][Full Text] [Related]
32. Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds.
Kleinpeter AB; Jureka AS; Falahat SM; Green TJ; Petit CM
J Biol Chem; 2018 Sep; 293(38):14659-14668. PubMed ID: 30076219
[TBL] [Abstract][Full Text] [Related]
33. Structural analysis and functional implications of the negative mTORC1 regulator REDD1.
Vega-Rubin-de-Celis S; Abdallah Z; Kinch L; Grishin NV; Brugarolas J; Zhang X
Biochemistry; 2010 Mar; 49(11):2491-501. PubMed ID: 20166753
[TBL] [Abstract][Full Text] [Related]
34. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
35. The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo.
Dong HJ; Wang ZH; Meng W; Li CC; Hu YX; Zhou L; Wang XJ
Viruses; 2018 Nov; 10(11):. PubMed ID: 30388805
[TBL] [Abstract][Full Text] [Related]
36. Development of an HTS assay for the search of anti-influenza agents targeting the interaction of viral RNA with the NS1 protein.
Maroto M; Fernandez Y; Ortin J; Pelaez F; Cabello MA
J Biomol Screen; 2008 Aug; 13(7):581-90. PubMed ID: 18594021
[TBL] [Abstract][Full Text] [Related]
37. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.
Wang BX; Wei L; Kotra LP; Brown EG; Fish EN
Viruses; 2017 May; 9(5):. PubMed ID: 28498306
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function.
Patil A; Anhlan D; Ferrando V; Mecate-Zambrano A; Mellmann A; Wixler V; Boergeling Y; Ludwig S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408177
[TBL] [Abstract][Full Text] [Related]
39. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.
Nogales A; Rodriguez L; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637750
[TBL] [Abstract][Full Text] [Related]
40. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
